Harmony Biosciences Holdings, Inc.
HRMY
$31.43
$0.491.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.87M | 39.78M | 45.56M | 49.48M | 46.09M |
| Total Depreciation and Amortization | 5.97M | 5.97M | 5.97M | 5.97M | 5.97M |
| Total Amortization of Deferred Charges | 161.00K | 163.00K | 166.00K | 169.00K | 175.00K |
| Total Other Non-Cash Items | 21.60M | 19.92M | 8.16M | 4.13M | 6.56M |
| Change in Net Operating Assets | 30.14M | 13.50M | -25.86M | 15.82M | 11.70M |
| Cash from Operations | 108.73M | 79.33M | 33.99M | 75.56M | 70.50M |
| Capital Expenditure | -71.00K | -4.00K | -128.00K | -513.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.72M | -19.59M | 2.49M | -6.67M | 748.00K |
| Cash from Investing | -4.79M | -19.59M | 2.36M | -7.19M | 745.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M |
| Issuance of Common Stock | 754.00K | 2.10M | 4.71M | 3.24M | 2.58M |
| Repurchase of Common Stock | 0.00 | -1.03M | -1.31M | -2.23M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.00M | -2.69M | -352.00K | -2.74M | -1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.95M | 57.05M | 36.00M | 65.63M | 70.07M |